Walmart, which is often dubbed the world’s biggest retailer, in reference to its revenue, still leads the way when it comes ...

Drug distributor McKesson missed estimates for third-quarter revenue on Wednesday, hurt by less-than-expected sales in its ...

Healthcare distributor and services company McKesson (NYSE:MCK) fell short of the market’s revenue expectations in Q4 CY2024, ...

Welcome to McKesson's third quarter fiscal 2025 earnings conference call. Please be advised that today's conference is being ...

Q3 2025 Earnings Call Transcript February 5, 2025 Operator: Welcome to McKesson’s Third Quarter Fiscal 2025 Earnings ...

Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors ...

McKesson (MCK) and AmerisourceBergen (ABC) are among the pharmaceutical wholesalers that have won a bid to dismiss antitrust allegations that ...

Baird raised the firm’s price target on McKesson (MCK) to $729 from $693 and keeps an Outperform rating on the shares. The firm said they are ...

Welcome to McKesson's Third Quarter Fiscal 2025 Earnings Conference Call. Please be advised that today's conference is being recorded. At this time, I'd like to turn the conference over to Rachel ...

McKesson beat earnings expectations with an adjusted EPS of $8.03, coming in just ahead of the projected $8.01. Revenue for Q3 came in at $95.3 billion, falling slightly short of the estimated $96 ...

McKesson inked a deal to buy a controlling interest in Prism Vision Holdings, as it also logged higher profit and revenue in its fiscal third quarter. The drug distributor said Wednesday that it ...

Vitalone confirmed the company raised its adjusted EPS guidance to a range of $32.55 to $32.95 for fiscal 2025, representing 19%-20% year-over-year growth. Management raised full-year guidance for ...